A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like
medicine tablet or capsule, but contains no active medicine) is safe and effective when taken
for 52 weeks with another antidepressant medicine.